Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093327 · ClinicalTrials.gov registry record · Phase 2
Acupuncture for Irritable Bowel Syndrome (IBS)
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 287
- Enrollment target
NCT00093327 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 287 participants.
The verdict
NCT00093327, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 287 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether acupuncture is effective in reducing the symptoms of irritable bowel syndrome (IBS).
Interventions
- PROCEDURE Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00093327
The ClinicalTrials.gov registry entry for NCT00093327 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT00093327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00093327 about?
NCT00093327 is a clinical study titled "Acupuncture for Irritable Bowel Syndrome (IBS)". The purpose of this study is to determine whether acupuncture is effective in reducing the symptoms of irritable bowel syndrome (IBS).
What is the current status of trial NCT00093327?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 287 participants. The study started on 2003-09. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00093327?
The interventions under investigation include: Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT00093327?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.